News & events
News
Researchers from The Australian National University (ANU) have exposed a fatal flaw in the deadly parasite that causes malaria - one of the world's biggest killers.
Amber Condell likes stories - both hearing them and telling them. That’s why she likes studying genetics.
A study led by researchers at ANU could lead to new treatments for combating drug-resistant malaria, as well as boost existing drugs.
In fiction and popular culture, parasitic characters appear as a metaphor for the threat and spread of disease.
My group focuses on understanding the function of integral membrane transporters and receptors from a structural perspective.
Professor Geoff McFadden has been awarded the Ralph Slatyer Medal for research in understanding the malaria parasite.
Events
The antimalarial drug amodiaquine has been around for nearly 60 years during which time it has been deployed as a monotherapy, then removed from recommendations due to toxicity fears, re-instated, and is now deployed in artemisinin-based combinations therapies to combat malaria.
As you read this abstract, your lungs are (I hope!) bringing live-sustaining oxygen into your body. Oxygen is required by our cells for one key purpose – to act as the final electron acceptor in the mitochondrial electron transport chain (ETC).
Shigella flexneri is an entero-pathogen that is considered a significant public health risk, causing shigellosis or bacillary dysentery, and accounts for the highest percentage of diarrheal deaths annually.
Scientific and technological advancements in the field of cell physiology over the last thirty years have uncovered the identities and functions of over sixty solute carriers which participate in the transport of amino acids in mammalian cells.
Many genes that have been recently identified as determinants of drug resistance in the malaria parasite encode membrane transport proteins (also known as transporters).